Urinary BTA: indicator of bladder cancer or of hematuria
作者： Makito Miyake , Steve Goodison , Wasia Rizwani , Shanti Ross , H. Bart Grossman
DOI: 10.1007/S00345-012-0935-9
关键词:
摘要: Background In this study, we investigated the influence of hematuria on performance bladder tumor antigen (BTA) tests in a clinical cohort and an experimental model.
springer.com
elsevier.com
sci-hub.se 参考文章(13)
Adrian Pilatz, Wolfgang Weidner, Thomas Bschleipfer, Arne Hauptmann, Gerson Lüdecke, Comparative Analysis of Sensitivity to Blood in the Urine for Urine-based Point-of-Care Assays (UBC rapid, NMP22 BladderChek and BTA-stat) in Primary Diagnosis of Bladder Carcinoma. Interference of Blood on the Results of Urine-based POC Tests Anticancer Research. ,vol. 32, pp. 2015- 2018 ,(2012)
Vincent Ravery, Michael Marberger, Vito Pansadoro, Cora N. Sternberg, Alain Meulemans, Francesco Pagano, Pierfrancesco Bassi, Dominique Le Guludec, Herbert Leyh, Emilio Bombardieri, Laura Ishak, Lothar Thomas, Pierre Conort, Laurent Boccon-Gibod, Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer. Clinical Chemistry. ,vol. 45, pp. 472- 477 ,(1999) , 10.1093/CLINCHEM/45.4.472
Robert J. Kinders, Helen Landicho, Re: The BTA stat test is nonspecific for hematuria: an experimental hematuria model. The Journal of Urology. ,vol. 168, pp. 2556- 2556 ,(2002) , 10.1016/S0022-5347(05)64207-3
Charles J. Rosser, Li Liu, Yijun Sun, Patrick Villicana, Molly McCullers, Stacy Porvasnik, Paul R. Young, Alexander S. Parker, Steve Goodison, Bladder Cancer Associated Gene Expression Signatures Identified by Profiling of Exfoliated Urothelia Cancer Epidemiology, Biomarkers & Prevention. ,vol. 18, pp. 444- 453 ,(2009) , 10.1158/1055-9965.EPI-08-1002
Rüdiger Heicappell, Ingrid C. Wettig, Martin Schostak, Markus Müller, Ursula Steiner, Thomas Sauter, Kurt Miller, Quantitative Detection of Human Complement Factor H-Related Protein in Transitional Cell Carcinoma of the Urinary Bladder European Urology. ,vol. 35, pp. 81- 87 ,(1999) , 10.1159/000019822
Joerg Hennenlotter, Severine Huber, Tilman Todenhöfer, Ursula Kuehs, David Schilling, Stefan Aufderklamm, Georgios Gakis, Christian Schwentner, Arnulf Stenzl, Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria Advances in Urology. ,vol. 2011, pp. 937561- 937561 ,(2011) , 10.1155/2011/937561
Ron Edgar, Michael Domrachev, Alex E Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Research. ,vol. 30, pp. 207- 210 ,(2002) , 10.1093/NAR/30.1.207
Virginia Urquidi, Steve Goodison, Jeongsoon Kim, Myron Chang, Yunfeng Dai, Charles J. Rosser, Vascular Endothelial Growth Factor, Carbonic Anhydrase 9, and Angiogenin as Urinary Biomarkers for Bladder Cancer Detection Urology. ,vol. 79, pp. 1185- ,(2012) , 10.1016/J.UROLOGY.2012.01.016
C Bruce, L Williams, R Root, H Murchison, G M Hass, T Jones, M Corey, D Enfield, R Kinders, Complement factor H or a related protein is a marker for transitional cell cancer of the bladder. Clinical Cancer Research. ,vol. 4, pp. 2511- 2520 ,(1998)
ÖMER ÖGE, DIDEM KOZACI, HAKAN GEMALMAZ, THE BTA STAT TEST IS NONSPECIFIC FOR HEMATURIA: AN EXPERIMENTAL HEMATURIA MODEL The Journal of Urology. ,vol. 167, pp. 1318- 1320 ,(2002) , 10.1016/S0022-5347(05)65290-1